TORONTO, May 29, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the Company is...

Khiron to Commence Trading on TSX Venture Exchange — First Canadian Cannabis Company with Core Operations in Colombia to List on Any Exchange Globally — — Khiron to Host...

Adent and Khiron Announce Closing of Subscription Receipt Financing TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) — Further to the press releases dated November 7, 2017, and December 27, 2017,...

Adent and Khiron Announce $6M Subscription Receipt Financing in Connection With the Business Combination TORONTO, Nov. 7, 2017 /CNW/ – Adent Capital Corp. (“Adent”) (NEX: ANT.H) and Khiron Life...

Exclusive Interview with Khiron Life Sciences CEO Alvaro Torres Colombia is a developing cannabis market that has captured the attention of many. A country known historically for being a...

Two privately-held cannabis companies based in Canada, Khiron Life Sciences and PharmaCielo, are now fully licensed by Colombia to produce low and high THC medical cannabis. Khiron disclosed the news...

Khiron First Company to Receive Licence for Cultivation of Medical Cannabis in Colombia TORONTO, Sept. 26, 2017 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports...